Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
Outcome measures in pediatric chronic inflammatory demyelinating polyradiculoneuropathy
Apoorva Guttikonda1, Ghazal Ahmad2, Parul Goyal3
1Department of Pediatrics, MetroHealth Medical Center, Cleveland, Ohio, USA.
Insights
Objective outcome measures are needed for children with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Serial grip strength and nerve conduction studies show significant motor improvements in children treated with IVIG.
Area of Science:
- Pediatric Neurology
- Neuromuscular Disorders
- Clinical Outcomes Assessment
Background:
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves in children.
- Objective outcome measures are crucial for monitoring treatment efficacy in pediatric CIDP.
- Current assessment methods may lack sensitivity or objectivity in this population.
Purpose of the Study:
- To evaluate the utility of serial grip strength measurements as an objective outcome measure in children with CIDP.
- To assess interval changes in motor function using grip strength and nerve conduction studies.
- To determine the feasibility of these measures in a clinical setting.
Main Methods:
- Retrospective review of 16 pediatric CIDP patients treated with intravenous immunoglobulin (IVIG).
- Serial grip strength measurements using a handheld dynamometer at clinic visits.
- Annual median motor nerve conduction studies, including F-wave latencies and compound muscle action potential amplitude.
Main Results:
- Significant improvements observed in both right (0.19 kg/month) and left (0.23 kg/month) grip strength over a mean follow-up of 2.9 years (p < 0.001).
- Median F-wave latencies also showed significant improvement (-0.23/month, p = 0.015).
- IVIG frequency less than 21 days was identified as a key factor for grip strength and distal compound muscle action potential amplitude improvement.
Conclusions:
- Serial grip strength measurements are a feasible and objective tool for assessing motor strength improvements in pediatric CIDP patients.
- These findings support the integration of grip strength into routine clinical assessments for children with CIDP undergoing immunotherapy.
- Nerve conduction studies complement grip strength in evaluating treatment response.
Introduction/Aims:
Objective outcome measures in children undergoing treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are lacking. The aim of the study was to record serial grip strength and motor nerve conduction studies to assess interval change.
Methods:
This was a retrospective review of 16 children (8 females and 8 males; median age, 9.7 years; interquartile range, 6-13 years) with CIDP followed at a tertiary children's hospital from 2013 to 2021. Subjects were treated with intravenous immunoglobulin (IVIG). Right and left grip strength measurements were obtained at each clinic visit using a handheld dynamometer. Annual right median motor nerve conduction study data were recorded during the study period.
Results:
Mean duration of follow-up was 2.9 years. Grip strength (right: 0.19 kg/month, p < 0.001; left 0.23 kg/month, p < 0.001) and median F-wave latencies (-0.23/month, p = 0.015) showed significant improvement over time. Akaike information criterion showed time + IVIG frequency <21 days as best fit for grip strength and distal compound muscle action potential amplitude.
Discussion:
Our study results indicate serial grip strength measurements are a feasible and objective way to assess motor strength improvement in children with CIDP receiving immunotherapy.

